会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明授权
    • Focus ring, plasma etching apparatus and plasma etching method
    • 聚焦环,等离子体蚀刻装置和等离子体蚀刻方法
    • US08192577B2
    • 2012-06-05
    • US12491962
    • 2009-06-25
    • Daiki SatohHideyuki KobayashiMasato Horiguchi
    • Daiki SatohHideyuki KobayashiMasato Horiguchi
    • H01L21/00
    • H01L21/67069H01J37/32642Y10S156/915
    • In a plasma etching apparatus for performing a plasma etching on a surface of a substrate mounted on a susceptor in a processing vessel, a focus ring is installed to surround the substrate and has a first region at an inner side on a surface thereof, in which an average surface roughness is small such that a reaction product produced during an etching processing is not captured to be deposited, and a second region at an outer side from the first region, in which an average surface roughness is large such that a reaction product produced during the etching process is captured to be deposited. A boundary between the first and the second region is a part where an etching amount is relatively significantly changed compared to other parts while the focus ring is equipped in the plasma etching apparatus and the plasma etching is performed on the substrate.
    • 在用于在安装在处理容器中的基座上的基板的表面进行等离子体蚀刻的等离子体蚀刻装置中,安装有聚焦环以围绕基板并且在其表面的内侧具有第一区域,其中 平均表面粗糙度小,使得在蚀刻处理期间产生的反应产物不被捕获以沉积,并且在平均表面粗糙度大的第一区域的外侧的第二区域,使得产生的反应产物 在蚀刻过程中被捕获以被沉积。 第一区域和第二区域之间的边界是与其他部分相比蚀刻量相对显着变化的部分,而在等离子体蚀刻装置中配备聚焦环,并且在基板上进行等离子体蚀刻。
    • 10. 发明申请
    • METHOD FOR REDUCTION, STABILIZATION AND PREVENTION OF RUPTURE OF LIPID RICH PLAQUE
    • 减少,稳定和防止破碎的富含PLAQUE的方法
    • US20110207742A1
    • 2011-08-25
    • US13096477
    • 2011-04-28
    • Hideyuki KobayashiYasunobu YoshinakaKimiyuki Shibuya
    • Hideyuki KobayashiYasunobu YoshinakaKimiyuki Shibuya
    • A61K31/497A61P9/10A61P7/02
    • A61K31/497A61K31/47A61K2300/00
    • There is to provide is an agent for reduction of a lipid rich plaque, stabilization of a lipid rich plaque and/or prevention of rupture of a lipid rich plaque in an atherosclerotic lesion comprising an effective amount of 2-[4-[2-(benzimidazole-2-ylthio)ethyl]piperazin-1-yl]-N-[2,4-bis(methylthio)-6-methyl-3-p yridyl]acetamide (hereinafter, referred to as compound 1), its pharmaceutically acceptable salt or a hydrate thereof and Pitavastatin, and a pharmaceutically acceptable carrier, wherein the agent is intended to be simultaneously administered, or separately administered with interval of time to a patient in need thereof There is also to provide a method for reduction of a lipid rich plaque, stabilization of a lipid rich plaque and/or prevention of rupture of a lipid rich plaque in an atherosclerotic lesion, comprising simultaneously administering, or separately administering with interval of time an effective amount of the compound 1, its pharmaceutically acceptable salt or a hydrate thereof and an effective amount of Pitavastatin to a patient in need thereof.
    • 提供的是减少富含脂质的斑块,稳定富含脂质的斑块和/或预防动脉粥样硬化病变中脂质丰富斑块破裂的药剂,其包含有效量的2- [4- [2-( 苯并咪唑-2-基硫基)乙基]哌嗪-1-基] -N- [2,4-双(甲硫基)-6-甲基-3-吡啶基]乙酰胺(以下称为化合物1),其药学上可接受的 盐或其水合物和匹伐他汀,以及药学上可接受的载体,其中所述试剂旨在同时施用或分开施用于有需要的患者的时间间隔。还提供降低富含脂质的方法 斑块,富含脂质的斑块的稳定化和/或预防动脉粥样硬化病变中富含脂质的斑块的破裂,其包括同时施用或分开施用有效量的化合物1,其药学上可接受的盐或水合物 并且对有需要的患者有效量的匹伐他汀。